263 related articles for article (PubMed ID: 35421533)
1. A robust post-insertion method for the preparation of targeted siRNA LNPs.
Swart LE; Koekman CA; Seinen CW; Issa H; Rasouli M; Schiffelers RM; Heidenreich O
Int J Pharm; 2022 May; 620():121741. PubMed ID: 35421533
[TBL] [Abstract][Full Text] [Related]
2. Development of a Microfluidic-Based Post-Treatment Process for Size-Controlled Lipid Nanoparticles and Application to siRNA Delivery.
Kimura N; Maeki M; Sato Y; Ishida A; Tani H; Harashima H; Tokeshi M
ACS Appl Mater Interfaces; 2020 Jul; 12(30):34011-34020. PubMed ID: 32667806
[TBL] [Abstract][Full Text] [Related]
3. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
4. Tailoring lipid nanoparticles for T-cell targeting in allergic asthma: Insights into efficacy and specificity.
Jürgens DC; Müller JT; Nguyen A; Merkel OM
Eur J Pharm Biopharm; 2024 May; 198():114242. PubMed ID: 38442794
[TBL] [Abstract][Full Text] [Related]
5. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Lipid Nanoparticles Containing Ionizable Cationic Lipids Using Design-of-Experiments Approach.
Terada T; Kulkarni JA; Huynh A; Chen S; van der Meel R; Tam YYC; Cullis PR
Langmuir; 2021 Jan; 37(3):1120-1128. PubMed ID: 33439022
[TBL] [Abstract][Full Text] [Related]
7. Importance of Process Parameters Influencing the Mean Diameters of siRNA-Containing Lipid Nanoparticles (LNPs) on the in Vitro Activity of Prepared LNPs.
Nakamura K; Aihara K; Ishida T
Biol Pharm Bull; 2022; 45(4):497-507. PubMed ID: 35370275
[TBL] [Abstract][Full Text] [Related]
8. Development of Lipidoid Nanoparticles for siRNA Delivery to Neural Cells.
Khare P; Dave KM; Kamte YS; Manoharan MA; O'Donnell LA; Manickam DS
AAPS J; 2021 Dec; 24(1):8. PubMed ID: 34873640
[TBL] [Abstract][Full Text] [Related]
9. Electrostatic adsorption of polyanions onto lipid nanoparticles controls uptake, trafficking, and transfection of RNA and DNA therapies.
Nabar N; Dacoba TG; Covarrubias G; Romero-Cruz D; Hammond PT
Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2307809121. PubMed ID: 38437543
[TBL] [Abstract][Full Text] [Related]
10. Efficient siRNA Delivery by Lipid Nanoparticles Modified with a Nonstandard Macrocyclic Peptide for EpCAM-Targeting.
Sakurai Y; Mizumura W; Murata M; Hada T; Yamamoto S; Ito K; Iwasaki K; Katoh T; Goto Y; Takagi A; Kohara M; Suga H; Harashima H
Mol Pharm; 2017 Oct; 14(10):3290-3298. PubMed ID: 28789523
[TBL] [Abstract][Full Text] [Related]
11. Flash nanoprecipitation assisted self-assembly of ionizable lipid nanoparticles for nucleic acid delivery.
Misra B; Hughes KA; Pentz WH; Samart P; Geldenhuys WJ; Bobbala S
Nanoscale; 2024 Apr; 16(14):6939-6948. PubMed ID: 38511623
[TBL] [Abstract][Full Text] [Related]
12. Lipid Nanoparticles Optimized for Targeting and Release of Nucleic Acid.
Jia Y; Wang X; Li L; Li F; Zhang J; Liang XJ
Adv Mater; 2024 Jan; 36(4):e2305300. PubMed ID: 37547955
[TBL] [Abstract][Full Text] [Related]
13. Increasing the siRNA knockdown efficiency of lipid nanoparticles by morphological transformation with the use of dihydrosphingomyelin as a helper lipid.
Hashimoto M; Yonezawa S; Furan S; Nitta C; Maeda N; Tomita K; Yokouchi A; Koide H; Asai T
Biomater Sci; 2023 May; 11(9):3269-3277. PubMed ID: 36939181
[TBL] [Abstract][Full Text] [Related]
14. Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells.
Basha G; Novobrantseva TI; Rosin N; Tam YY; Hafez IM; Wong MK; Sugo T; Ruda VM; Qin J; Klebanov B; Ciufolini M; Akinc A; Tam YK; Hope MJ; Cullis PR
Mol Ther; 2011 Dec; 19(12):2186-200. PubMed ID: 21971424
[TBL] [Abstract][Full Text] [Related]
15. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver.
Zhang R; El-Mayta R; Murdoch TJ; Warzecha CC; Billingsley MM; Shepherd SJ; Gong N; Wang L; Wilson JM; Lee D; Mitchell MJ
Biomater Sci; 2021 Feb; 9(4):1449-1463. PubMed ID: 33404020
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of lipid nanoparticle to lymphatic endothelial cells via anti-podoplanin antibody.
Sakurai Y; Abe N; Yoshikawa K; Oyama R; Ogasawara S; Murata T; Nakai Y; Tange K; Tanaka H; Akita H
J Control Release; 2022 Sep; 349():379-387. PubMed ID: 35787913
[TBL] [Abstract][Full Text] [Related]
17. A tale of nucleic acid-ionizable lipid nanoparticles: Design and manufacturing technology and advancement.
De A; Ko YT
Expert Opin Drug Deliv; 2023 Jan; 20(1):75-91. PubMed ID: 36445261
[TBL] [Abstract][Full Text] [Related]
18. Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery.
Wang X; Liu S; Sun Y; Yu X; Lee SM; Cheng Q; Wei T; Gong J; Robinson J; Zhang D; Lian X; Basak P; Siegwart DJ
Nat Protoc; 2023 Jan; 18(1):265-291. PubMed ID: 36316378
[TBL] [Abstract][Full Text] [Related]
19. Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells.
Ferraresso F; Strilchuk AW; Juang LJ; Poole LG; Luyendyk JP; Kastrup CJ
Mol Pharm; 2022 Jul; 19(7):2175-2182. PubMed ID: 35642083
[TBL] [Abstract][Full Text] [Related]
20. Assessing the heterogeneity level in lipid nanoparticles for siRNA delivery: size-based separation, compositional heterogeneity, and impact on bioperformance.
Zhang J; Pei Y; Zhang H; Wang L; Arrington L; Zhang Y; Glass A; Leone AM
Mol Pharm; 2013 Jan; 10(1):397-405. PubMed ID: 23210488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]